Bactiguard Holding — Proxy Solicitation & Information Statement 2025

Apr 3, 2025

Bactiguard

The Nomination Committee's proposal for Board of Directors to the 2025 Annual General Meeting

The Nomination Committee of Bactiguard Holding AB (the "Company") today informs about the proposal regarding the composition of the Board of Directors for the Annual General Meeting on 15 May 2025.

The Nomination Committee proposes re-election of Thomas von Koch, Dr Richard Kuntz, Professor Anna Martling, Magdalena Persson and Jan Ståhlberg as Board Members. Thomas von Koch is proposed to be re-elected as the Chairman of the Board of Directors.

The Nomination Committee's other proposals will be made public in the notice convening the Annual General Meeting to be held on 15 May 2025.

The Nomination Committee for the 2025 Annual General Meeting consists of Helena Borglund (Chairman of the Nomination Committee), appointed by TomBact AB (a company controlled by Thomas von Koch), Christian Kinch, appointed by GIDL Invest AB (a company controlled by Christian Kinch), Mats J Andersson, appointed by Nordea Fonder AB, Jannis Kitsakis, appointed by the Fourth AP Fund, and Jan Ståhlberg, appointed by himself.

For further information, please contact:
Patrick Bach, CFO +46 761 295 911
Nina Nornholm, Head of Communication & Investor Relations +46 708 550 356

About Bactiguard

Bactiguard is a global MedTech company developing safe and biocompatible technology to prevent medical device related infections. The company's unique technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard's infection prevention technology and solutions decrease patient suffering, save lives, and unburden healthcare resources while also fighting against antimicrobial resistance, one of the most serious threats to global health and modern medicine.

Bactiguard operates through license partnerships with leading global MedTech companies that apply the technology to their medical devices and sell them under their own brand or co-branded with Bactiguard. The company also has a portfolio of wound management products. Bactiguard is headquartered in Stockholm and listed on Nasdaq Stockholm.

Read more about Bactiguard: www.bactiguard.com
Follow Bactiguard on LinkedIn